Literature DB >> 19216731

Genetic control of disease in an experimental model for Sjögren's syndrome.

Asa Andersson.   

Abstract

Sjögren's syndrome is an autoimmune disease with a complex etiology depending on hereditary and environmental factors. The disease is characterized by lymphocytic infiltration and inflammation in the salivary and lacrimal glands, leading to oral and ocular dryness. To understand the genetic susceptibility in Sjögren's syndrome, studies of disease phenotypes have been performed in the non-obese diabetic (NOD) mouse. By the identification of genetic regions controlling development of autoimmune exocrinopathy in the NOD mouse and by reducing one of these regions considerably, Nguyen et al. in a recent issue of Arthritis Research and Therapy propose candidate genes for development of Sjögren's syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19216731      PMCID: PMC2688230          DOI: 10.1186/ar2583

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  9 in total

1.  Genetic interactions in Eae2 control collagen-induced arthritis and the CD4+/CD8+ T cell ratio.

Authors:  Jenny Karlsson; Martina Johannesson; Therese Lindvall; Patrik Wernhoff; Rikard Holmdahl; Asa Andersson
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 2.  Horizons in Sjögren's syndrome genetics.

Authors:  Pamela H Williams; Beth L Cobb; Bahram Namjou; R Hal Scofield; Amr H Sawalha; John B Harley
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice.

Authors:  M Johannesson; J Karlsson; P Wernhoff; K S Nandakumar; A-K Lindqvist; L Olsson; A D Cook; A Andersson; R Holmdahl
Journal:  Genes Immun       Date:  2005-05       Impact factor: 2.676

4.  OX40 ligand shuts down IL-10-producing regulatory T cells.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Shino Hanabuchi; Olivia A Perng; Michel Gilliet; F Xiao-Feng Qin; Yong-Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

5.  A novel NOD-derived murine model of primary Sjögren's syndrome.

Authors:  C P Robinson; S Yamachika; D I Bounous; J Brayer; R Jonsson; R Holmdahl; A B Peck; M G Humphreys-Beher
Journal:  Arthritis Rheum       Date:  1998-01

6.  Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.

Authors:  Smruti J Killedar; Smruti Y Killedar; Sarah E Eckenrode; Richard A McIndoe; Jin-Xiong She; Cuong Q Nguyen; Ammon B Peck; Seunghee R Cha; Seunghee Cha
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

7.  Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

Authors:  Ikuo Takeda; Shoji Ine; Nigel Killeen; Lishomwa C Ndhlovu; Kazuko Murata; Susumu Satomi; Kazuo Sugamura; Naoto Ishii
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.

Authors:  Seunghee Cha; Hiroyuki Nagashima; Vinette B Brown; Ammon B Peck; Michael G Humphreys-Beher
Journal:  Arthritis Rheum       Date:  2002-05

9.  Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.

Authors:  Cuong Q Nguyen; Janet G Cornelius; Lauren Cooper; Jonathan Neff; Joann Tao; Byung Ha Lee; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.